Notice to Pension Funds, Asset Managers, and Fiduciaries: The lawsuit alleges CVRx’s Barostim growth relied partly on alleged kickbacks and false claims to government health programs, raising institutional investor securities recovery and ERISA questions.

NEW YORK, Nov. 12, 2026 /PRNewswire/ — SueWallSt notifies pension funds, asset managers, and other institutional investors in CVRx, Inc. (Nasdaq: CVRX) that a class action lawsuit has been filed on behalf of shareholders who purchased securities between July 25, 2023 and August 6, 2026. Find out if you qualify to recover losses. You may also contact Joseph E. Levi, Esq. at jlevi@SueWallSt.com or (888) SueWallSt.

Institutional portfolios holding CVRX reportedly absorbed a single-session decline of approximately 60%, or $3.55 per share, following the Company’s August 6, 2026 disclosures. To be considered for lead plaintiff, investors must file by January 8, 2027.

Notice to Institutional Holders

The pleading asserts that CVRx did not disclose that its sales growth was driven in part by improper marketing of Barostim, kickbacks to healthcare providers, and false information supplied to government health insurance programs. The complaint charges that this conduct violated the False Claims Act and Anti-Kickback Statute. Assurances about a stabilized sales force realignment are also challenged as misleading.

On August 6, 2026, CVRx reported that it had received a Department of Justice civil investigative demand on May 14, 2026, and it lowered its outlook the same day. As averred, these announcements corrected prior alleged misstatements, and fund holdings bore the resulting decline.

ERISA Considerations for Institutional Investor Securities Recovery

Barostim is the only device CVRx sells, and Medicare reimbursement is central to its adoption. For trustees and plan sponsors, the alleged government program exposure therefore reaches the core investment thesis behind any position held during the Class Period.

“Institutional investors play a critical role in securities class actions. The complaint alleges that CVRx’s reported growth rested partly on sales practices that are now the subject of a Department of Justice False Claims Act inquiry. Fiduciaries who held CVRX during the Class Period have good reason to assess what that alleged exposure cost their beneficiaries.” — Joseph E. Levi, Esq.

Fiduciary Obligations and Recovery Options

• ERISA fiduciaries are generally expected to act prudently with plan assets, which can include evaluating potential securities claims connected to holdings such as CVRX.
• The claims are pleaded under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5 in the U.S. District Court for the District of Minnesota.
• A lead plaintiff with substantial losses can oversee litigation strategy, recommend counsel subject to court approval, and monitor any settlement discussions.
• Institutions that do not seek appointment generally remain absent class members and may still share in any recovery.
• Holdings across multiple funds, separate accounts, and sub-advised mandates can be compiled into a single loss review.

Learn more about the case and your options or call (888) SueWallSt.

WHY SUEWALLST: SueWallSt is powered by Levi & Korsinsky LLP. Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured billions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

Frequently Asked Questions About the CVRX Lawsuit

Q: When did CVRx, Inc. allegedly mislead investors? A: The Class Period runs from July 25, 2023 to August 6, 2026. The complaint alleges that corrective disclosures revealed information that caused a significant stock decline.

Q: What court was the CVRX class action filed in? A: The case was filed in the United States District Court for the District of Minnesota, governed by the Private Securities Litigation Reform Act of 1995.

Q: Who are the defendants named in the CVRX lawsuit? A: The complaint names CVRx, Inc. and individual defendants including senior executives who signed SEC filings, made public statements, or certified financial disclosures under Sarbanes-Oxley.

Q: What do CVRX investors need to do right now? A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery. No immediate action is required to remain eligible as an absent class member.

Q: What is a lead plaintiff and why does it matter? A: A lead plaintiff is the investor appointed by the court to represent the entire class. Lead plaintiffs are typically investors with the largest documented losses. Being appointed does not increase individual recovery but gives direct oversight of how the case is run.

Q: What if I already sold my CVRX shares — can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought during the Class Period and sold at a loss may still be eligible to participate.

Q: What if I live outside the United States? A: U.S. securities class actions generally cover purchases on U.S. exchanges regardless of the investor’s country of residence.

Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in the securities class action, such cases are generally handled on a contingency basis, with any attorneys’ fees and expenses subject to court approval.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@SueWallSt.com
Tel: (888) SueWallSt
Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

View original content to download multimedia:https://www.prnewswire.com/news-releases/cvrx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-cvrx-inc-securities-lawsuit—contact-suewallst-302937459.html

SOURCE SueWallSt.com